XARELTO Drug Profile, 2024: XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues (DrugPatentWatch Business Intelligence Reports) (Original PDF from Publisher)

Original price was: $249.00.Current price is: $25.00.

Description

XARELTO Drug Profile, 2024 XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues (DrugPatentWatch Business

The following important facets of XARELTO are covered in this report:

United States patents
Expired US patents
Patent challenges under FDA Paragraph IV
District Court dispute pertaining to patents
Patent cases before the Patent Trial and Appeal Board (PTAB)
European certificates of supplemental protection (SPCs)
Clinical studies
The cost of drugs
Revenues from sales each year
Suppliers of finished goods
Sources of raw active pharmaceutical ingredients (APIs)

 

Additional information

Published Year

2024

Language

‎English

Publisher

Other Publisher

Edition

1 st

Format

Publisher PDF

File Size

900

ISBN

8875923647

Related Products

Reviews

There are no reviews yet.

Be the first to review “XARELTO Drug Profile, 2024: XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues (DrugPatentWatch Business Intelligence Reports) (Original PDF from Publisher)”

Your email address will not be published. Required fields are marked *